Kullak-Ublick GA - Search Results

1

Current concepts of mechanisms in drug-induced hepatotoxicity.

Russmann S, Kullak-Ublick GA, Grattagliano I. Russmann S, et al. Curr Med Chem. 2009;16(23):3041-53. doi: 10.2174/092986709788803097. Curr Med Chem. 2009. PMID: 19689281 Free PMC article. Review.

2

Mechanisms of cholestasis.

Kullak-Ublick GA, Meier PJ. Kullak-Ublick GA, et al. Clin Liver Dis. 2000 May;4(2):357-85. doi: 10.1016/s1089-3261(05)70114-8. Clin Liver Dis. 2000. PMID: 11232196 Review.

3

Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.

Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C. Lang C, et al. Pharmacogenet Genomics. 2007 Jan;17(1):47-60. doi: 10.1097/01.fpc.0000230418.28091.76. Pharmacogenet Genomics. 2007. PMID: 17264802

4

Phynx: an open source software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice research database and other health care databases.

Egbring M, Kullak-Ublick GA, Russmann S. Egbring M, et al. Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):38-44. doi: 10.1002/pds.1860. Pharmacoepidemiol Drug Saf. 2010. PMID: 19777533

5

Pharmacogenetics of drug-induced liver injury.

Russmann S, Jetter A, Kullak-Ublick GA. Russmann S, et al. Hepatology. 2010 Aug;52(2):748-61. doi: 10.1002/hep.23720. Hepatology. 2010. PMID: 20607838 Review.

6

Diagnosis of melanoma under concomitant natalizumab therapy.

Vavricka BM, Baumberger P, Russmann S, Kullak-Ublick GA. Vavricka BM, et al. Mult Scler. 2011 Feb;17(2):255-6. doi: 10.1177/1352458510389629. Epub 2010 Dec 21. Mult Scler. 2011. PMID: 21177318 No abstract available.

7

Evaluation of medication safety in the discharge medication of 509 surgical inpatients using electronic prescription support software and an extended operational interaction classification.

Frölich T, Zorina O, Fontana AO, Kullak-Ublick GA, Vollenweider A, Russmann S. Frölich T, et al. Eur J Clin Pharmacol. 2011 Dec;67(12):1273-82. doi: 10.1007/s00228-011-1081-9. Epub 2011 Jun 14. Eur J Clin Pharmacol. 2011. PMID: 21671021 Free article.

8

Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System).

Guzek M, Zorina OI, Semmler A, Gonzenbach RR, Huber M, Kullak-Ublick GA, Weller M, Russmann S. Guzek M, et al. Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):930-8. doi: 10.1002/pds.2197. Epub 2011 Jul 20. Pharmacoepidemiol Drug Saf. 2011. PMID: 21774031

9

Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients.

Fritz D, Ceschi A, Curkovic I, Huber M, Egbring M, Kullak-Ublick GA, Russmann S. Fritz D, et al. Eur J Clin Pharmacol. 2012 Aug;68(8):1209-19. doi: 10.1007/s00228-012-1241-6. Epub 2012 Feb 29. Eur J Clin Pharmacol. 2012. PMID: 22374346 Free article.

10

Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients.

Zorina OI, Haueis P, Semmler A, Marti I, Gonzenbach RR, Guzek M, Kullak-Ublick GA, Weller M, Russmann S. Zorina OI, et al. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):872-80. doi: 10.1002/pds.3279. Epub 2012 Apr 20. Pharmacoepidemiol Drug Saf. 2012. PMID: 22517594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters